Imperial College of Science, Technology and Medicine;Biogen Idec MA Inc.
发明人:
Roy Lobb,Charles Pusey,Andrew Allen
申请号:
US14158764
公开号:
US20140234299A1
申请日:
2014.01.17
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention provides methods for the treatment, and pharmaceuticals for use in the treatment, of mammalian subjects in, or at risk of chronic renal failure, or at risk of a need for renal replacement therapy. The methods involve the administration of certain integrin antagonists.